A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis

Carol A. Hitchon, Philip Alex, Lawrence B. Erdile, Mark B. Frank, Igor Dozmorov, Yuhong Tang, Keng Wong, Michael Centola, Hani S. El-Gabalawy

Research output: Contribution to journalArticle

72 Scopus citations

Abstract

Objective. Early inflammatory arthritis is clinically heterogenous and biologically-based indicators are needed to distinguish severe from self-limited disease. Anti-cyclical citrullinated peptides (CCP) have been identified as potential prognostic markers in early arthritis cohorts. Since cytokine networks are known to play a critical role in the pathogenesis of rheumatoid arthritis (RA) and other forms of inflammatory arthritis, a panel of pro- and antiinflammatory cytokines was measured to identify biologically-based subsets of early arthritis, relating cytokine profiles to clinical measures and to the presence of RA-associated autoantibodies. Methods. Plasma concentrations of cytokines [interleukin 1β (IL-1β), IL-2, IL-4, IL-5, IL-6, IL-7, CXCL8 (IL-8), IL-10, IL-12p70, IL-13, IL-17, granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interferon-γ (IFN-γ), CCL2 (monocyte chemoattractant protein-1, MCP-1), CCL4 (MIP-1β), and tumor necrosis factor-α (TNF-α)] were measured in patients with early, untreated inflammatory arthritis [symptom duration ≤ 12 months; ≥ 1 swollen joint; RA, n = 41; undifferentiated arthritis (UA), n = 23]. Cytokine expression patterns were determined using cluster analysis. Results. Both pro- and antiinflammatory cytokines were elevated in patients over controls (n = 21). RA clustered into subgroups based solely on cytokine profiles. The "mild" RA subgroup (n = 23) had higher CCL4 (MIP-1β), CXCL8 (IL-8), IL-2, IL-12, IL-17, IL-5, and IL-10 levels, lower IL-6, IFN-γ, GM-CSF, and IL-4 levels, less CCP positivity (52% vs 82%; p < 0.05), and lower CCP titers [71 (78) vs 153 (94); p < 0.01], but similar erythrocyte sedimentation rate, C-reactive protein, and joint counts compared to the "severe" RA groups. CCL4 (MIP-1β), IL-13, IL-12, TNF-α, and IL-4 best distinguished the groups. Combining UA with RA samples preserved cytokine subgroups and strengthened the autoantibody associations. Fewer UA patients in the "mild" cluster (n = 16) were RF-positive (24% vs 100%; p < 0.002) or CCP-positive (24% vs 66%; p < 0.08) compared to the "severe" group. Conclusion. Early untreated inflammatory arthritis can be categorized into distinct subgroups based on cytokine profiles. These subgroups are associated with CCP and RF autoantibodies. Integration of cytokine profiles with autoantibody status may assist prognostication and treatment decisions in these patients.

Original languageEnglish (US)
Pages (from-to)2336-2346
Number of pages11
JournalJournal of Rheumatology
Volume31
Issue number12
StatePublished - Dec 1 2004

    Fingerprint

Keywords

  • Arthritis
  • Autoantibodies
  • Chemokines
  • Citrulline
  • Cytokines
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Hitchon, C. A., Alex, P., Erdile, L. B., Frank, M. B., Dozmorov, I., Tang, Y., Wong, K., Centola, M., & El-Gabalawy, H. S. (2004). A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. Journal of Rheumatology, 31(12), 2336-2346.